MedTrace Logo

Headache Ear Auditory Dizziness Sinus (HEADS) Registry

NCT07754266 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2026-08-10

No results posted yet for this study

Summary

The Headache, Ear, Auditory, Dizziness, Sinus (HEADS) Registry is a study over time of individuals living in the United States who experience sinus, vestibular, auditory, and headache symptoms. Through an online portal, participants are asked questions about their symptoms, how they have affected their lives, and how effectively they have managed them. This information is then used to better understand these symptoms and to improve patient diagnosis and treatment.

Some potential research benefits of the HEADS Registry include:

* Improving healthcare professionals' understanding of the causes of specific head and neck symptoms.
* Reducing delays in diagnosis and the use of inappropriate tests, medications, and surgeries.
* Finding the most effective treatments for sinus, vestibular, and auditory disorders.
* Providing participants the opportunity to be contacted for additional important research related to sinus, vestibular, and auditory disorders.

All U.S. residents over the age of majority who experience sinus, vestibular, and auditory symptoms, with or without migraine, are eligible to participate. Enrollment is voluntary, confidential, and free of charge.

Conditions

  • Headache Disorders
  • Dizziness
  • Vestibular Diseases
  • Sinus Disease
  • Vestibular Disorder
  • Migraine Disorders
  • Headache
  • Migraine
  • Facial Pain

Sponsors & Collaborators

  • Lumiio Inc.

    collaborator UNKNOWN

  • Pfizer

    collaborator INDUSTRY

  • Association of Migraine Disorders

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-06
Primary Completion
2033-12-31
Completion
2033-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07754266 on ClinicalTrials.gov